{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P08833",
      "entity_text" : "IGFBP-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ12823",
      "entity_text" : "CALERIE-II trial",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Interestingly, unlike in rodents, the recent human CALERIE-II trial, which evaluated the effect of 15% reduction in energy intake over 2 years, shows no decrease in serum circulating IGF-1 concentration but rather increased serum IGFBP-1 and decreased IGF-1 : IGFBP-1 ratio levels; this suggests an overall reduction in IGF-1 bioactivity in humans post-calorie restriction.",
  "reading_complete" : "2020-08-08T15:04:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:03:14Z",
  "trigger" : "increased",
  "evidence" : [ "CALERIE-II trial, which evaluated the effect of 15% reduction in energy intake over 2 years, shows no decrease in serum-circulating IGF-1 concentration but rather increased serum IGFBP-1" ],
  "pmc_id" : "5992590",
  "score" : 0
}